Ahrens Investment Partners’s BlackRock Health Sciences Trust BME Stock Holding History
Bought
Maintained
Sold
Other funds holding BME
NRW
CA
Ahrens Investment Partners's BME Position: Q1 2023 in Review
Ahrens Investment Partners opened a new position in BlackRock Health Sciences Trust (BME) in Q1 2023: 1,900 shares worth $79.5K. The stake represents 0.04% of the portfolio and ranks #252 among its holdings. This is a return to the name: Ahrens Investment Partners previously reported a position in BME as recently as Q2 2022.
Ahrens Investment Partners first reported a position in BME in Q2 2020 and has held it in 10 quarters since. The position peaked at $3.56M in Q4 2020. 71 funds tracked by Wall St. Rank hold BME as of Q1 2023.
- Ahrens Investment Partners held 1,900 shares of BlackRock Health Sciences Trust worth $79.5K as of Q1 2023.
- BlackRock Health Sciences Trust was a new Ahrens Investment Partners position in Q1 2023.
- BlackRock Health Sciences Trust made up 0.04% of Ahrens Investment Partners's portfolio in Q1 2023, its #252 holding.
- Ahrens Investment Partners first reported a position in BlackRock Health Sciences Trust in Q2 2020 and has held it in 10 quarters since.
- Ahrens Investment Partners's BlackRock Health Sciences Trust position peaked at $3.56M in Q4 2020.
- 71 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q1 2023.
Based on Ahrens Investment Partners's 13F filing for Q1 2023, filed 24 Apr 2023.